VentriPoint Diagnostics (CVE:VPT) Trading Down 23.3% – Time to Sell?

VentriPoint Diagnostics Ltd. (CVE:VPT) shares fell 23.3% during mid-day trading on Friday . The company traded as low as C$0.12 and last traded at C$0.12. 1,797,794 shares were traded during trading, an increase of 540% from the average session volume of 280,948 shares. The stock had previously closed at C$0.15.

VentriPoint Diagnostics Stock Performance

The business’s fifty day simple moving average is C$0.10 and its 200-day simple moving average is C$0.13. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The firm has a market capitalization of C$18.65 million, a PE ratio of -3.55 and a beta of 0.39.

About VentriPoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.